What is behind Hair Loss & Thinning
TGF-β / Smad signaling — the builder that lays down collagen and directs repair, and the same hand that, overused, drives fibrosis. Evidence B — Preclinical.
The liver-made carrier protein that binds circulating sex hormones — the buffer that decides how much androgen is free to reach the follicle.
Dihydrotestosterone — the potent 5α-reductase product that binds the dermal-papilla androgen receptor and drives follicular miniaturization. Evidence A — Human trial evidence.
The transcription factor that commands the body's own antioxidant and detoxification arsenal. Evidence A — Human trial evidence.
The master inflammatory switch — indispensable to defend against threat, corrosive when it never stands down. Evidence B — Preclinical.
HIF-1α — the low-oxygen sensor that reprograms metabolism to adapt, and a driver of disease when chronically switched on. Evidence A — Human trial evidence.
Insulin sensitivity — how readily cells respond to insulin, the linchpin of metabolic health. Evidence B — Preclinical.
Fasting insulin — a sensitive marker of insulin resistance; chronically high levels signal metabolic strain. Evidence A — Human trial evidence.
5-alpha-reductase converts testosterone into dihydrotestosterone, the far more potent androgen. It is the step finasteride blocks, and the step the anti-androgenic botanicals act on. It matters in the scalp, the prostate and the skin. Evidence B — Preclinical.
Follicular oxidative stress â the reactive-oxygen burden that ages the hair follicle and drives shedding and graying. Evidence B — Preclinical.
Prostaglandin D2 — one lipid signal with two receptors: DP1 in the brain, where it is the most potent sleep-promoting substance known, and DP2/GPR44 in the scalp, where it suppresses the hair growth phase. Evidence B — Preclinical.
Pattern hair loss. The follicle is not lost â it miniaturizes, producing progressively finer and shorter hairs over successive cycles, until what grows is too fine to cover the scalp. Androgen-driven, and the most common cause of hair loss in both sexes.
Evidence on these pathways
Insulin Sensitivity → Women's Hormonal Balance. “A metabolic syndrome of obesity-related and/or intrinsic insulin resistance occurs in about half of PCOS patients, and the compensatory hyperinsulinism has tissue-selective effects, which include aggravation of hyperandrogenism.” — The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews, 2016, 37(5), 467-520. doi:10.1210/er.2015-1104
Insulin Sensitivity → Liver Integrity. “IR worsens NAFLD by increasing the accumulation of free fatty acids (FFAs) in the liver.” — Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin. Exploration of Medicine, 2020, 1, 287-306. doi:10.37349/emed.2020.00019
Insulin Sensitivity → Micronutrient Status. “In diabetes, insulin resistance in renal tissue inhibits magnesium reabsorption and contributes to the hypomagnesemia observed in these patients.” — Hypomagnesemia With Metformin Use in Diabetes Mellitus: A Case and Narrative Review. Kidney Medicine, 2025, volume 7, article 101030. doi:10.1016/j.xkme.2025.101030
Insulin Sensitivity → Diabetic Neuropathy. “Acanthosis nigricans (AN) is associated with insulin resistance, fatty liver, hyperlipidemia and glucose intolerance, all of which are risk factors for neuropathy.” — Corneal nerve loss in adolescents with obesity and acanthosis nigricans. PLOS ONE, 2024, vol 19, e0309761. doi:10.1371/journal.pone.0309761
Formulas that act on these pathways
Acts on 11 of these pathways: TGF-β / Smad, SHBG, DHT, Nrf2, NF-κB, Insulin Sensitivity, Fasting Insulin, 5-Alpha-Reductase, Follicular Oxidative Stress, Prostaglandin D2, Androgenetic Alopecia.
Acts on 5 of these pathways: TGF-β / Smad, Nrf2, NF-κB, Insulin Sensitivity, Fasting Insulin.
Acts on 5 of these pathways: Nrf2, NF-κB, HIF-1α, Insulin Sensitivity, Fasting Insulin.
Acts on 4 of these pathways: TGF-β / Smad, Nrf2, NF-κB, Insulin Sensitivity.
Acts on 4 of these pathways: Nrf2, NF-κB, Insulin Sensitivity, Fasting Insulin.
Acts on 4 of these pathways: Nrf2, NF-κB, Insulin Sensitivity, Fasting Insulin.
What this page does not claim
This page names the pathways involved and the published evidence on each. It does not claim that any formula treats, cures or prevents Hair Loss & Thinning. A pathway opens here only on graded, published evidence, under a standard fixed before the evidence was gathered, and every figure above carries its grade.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.